Study of CRB-701 for solid tumors with nectin-4
Part of Cancer clinical trials.
This trial tests a new drug, CRB-701, for people with advanced solid tumors that have a protein called nectin-4 on their surface. It might be an option if other treatments have stopped working or are not available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of advanced solid tumor that has the nectin-4 protein.
- Your tumor has gotten worse after trying all standard treatments, or there are no other proven treatments available.
- You do not have active or uncontrolled cancer that has spread to the brain.
- You have not had another type of cancer in the past.
- You do not have serious heart, liver, lung, or nerve problems, and your diabetes is well-controlled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called DB-1419 for people with advanced solid tumors that have not responded to other treatments. It is designed to target a protein called B7-H3 on cancer cells, and may help shrink tumors or slow their growth.
This trial tests a new drug called CX-801 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This study tests a new drug, CRB-601-01, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and can help shrink tumors.
This trial tests a new drug called LNF2105 in people with advanced solid tumors that have not responded to other treatments. The drug targets a protein called Nectin-4 found on many cancer cells, and researchers want to see if LNF2105 can help shrink or control these tumors.
This trial tests a new drug called SC-101 in people with advanced solid tumors that have not responded to other treatments. It may be an option if your tumor shows a specific protein called Nectin-4, which the drug targets.
This trial tests a new drug, SC-101, for people with advanced cancers that have a specific change in the NECTIN4 gene. It aims to see if the drug can help shrink or slow the cancer.
Hear when a new Solid Tumor, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.